# Filing Detail

Form DRS - Draft Registration Statement:
SEC Accession No. 0001628279-21-000266
Filing Date
2021-05-06
Accepted
2021-05-06 17:07:46
Documents
9

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS | 2138682
2 |  | business1c3.jpg | GRAPHIC | 1767978
3 |  | business2c2.jpg | GRAPHIC | 1533685
4 |  | business3c1a.jpg | GRAPHIC | 660580
5 |  | business4f1.jpg | GRAPHIC | 802103
6 |  | business5d1a.jpg | GRAPHIC | 1253151
7 |  | business6e1a.jpg | GRAPHIC | 562885
8 |  | business7c1.jpg | GRAPHIC | 1636095
9 |  | prospectuscover1b2.jpg | GRAPHIC | 4421406
| Complete submission text file | 0001628279-21-000266.txt |  | 17095183

Mailing Address 101 E. 6TH STREET SUITE 350 VANCOUVER WA 98660
Business Address 101 E. 6TH STREET SUITE 350 VANCOUVER WA 98660 (360) 949-1041
AbSci Corp (Filer) CIK: 0001672688 (see all company filings)

EIN.: 453931977 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-04799 | Film No.: 21898862
SIC: 8731 Services-Commercial Physical & Biological Research